- Consolidated Revenues grew 2.0%, and increased 7.8% as adjusted for divestitures and on a constant currency basis
- Third quarter GAAP net income of $18.7 million, or $0.28 per diluted share, and non-GAAP net income of $3.3 million, or $0.05 per diluted share
- $348.7 million of cash and cash equivalents and no debt at quarter end
- Updates 2022 full-year outlook reflecting approximately 10% revenue growth over 2021 adjusted for divestitures
MINNEAPOLIS & REHOVOT, Israel — (BUSINESS WIRE) — November 10, 2022 — Stratasys Ltd. (Nasdaq: SSYS), a leader in polymer 3D printing solutions, today announced financial results for the third quarter of 2022.
Third Quarter 2022 Financial Results Compared to Third Quarter 2021:
- Consolidated revenue of $162.2 million, up 2.0% compared to $159.0 million; adjusted revenue excluding divestitures and on a constant currency basis increased 7.8%.
- GAAP gross margin of 43.6% versus 42.9%.
- Non-GAAP gross margin of 48.5%, compared to 48.2%.
- GAAP operating loss of $15.6 million, compared to a GAAP operating loss of $21.9 million.
- Non-GAAP operating income of $4.5 million, versus non-GAAP operating income of $1.8 million.
- GAAP net income of $18.7 million, or $0.28 per diluted share, compared to net loss of $18.1 million, or ($0.28) per diluted share.
- Non-GAAP net income of $3.3 million, or $0.05 per diluted share, versus non-GAAP net income of $0.5 million, or $0.01 per diluted share.
- Adjusted EBITDA of $9.9 million, compared to $7.8 million.
- $18.4 million of cash used by, compared to $3.0 million of cash generated from, operating activities, reflecting cash use for a continued augmentation of inventories.
Dr. Yoav Zeif, Stratasys’ Chief Executive Officer, said “We delivered our highest third quarter revenue in seven years. This was driven by 18.9% growth in our systems, excluding divestitures and on a constant currency basis. We have now achieved five consecutive quarters of positive earnings, demonstrating our unique ability to generate profitable growth even while navigating a challenging global economic backdrop that includes prolonged customer sales cycles and delayed consumables purchases.”
“As the leading provider of comprehensive polymer additive manufacturing products, software, and services solutions, we continue to enhance our core competencies and evolve our offerings to outpace our customers’ expanding needs. We are excited about the significant expansion of our materials portfolio across multiple technologies, which we believe will drive higher-margin consumables sales in the coming years. In addition, as part of our growth strategy we will keep selectively adding and incubating complementary new technology-driven businesses that we expect will spur incremental growth in the future. Stratasys is ideally positioned to provide the necessary solutions to catalyze our customers’ ongoing transformation from prototyping to additive manufacturing at scale while creating long-term value for all of our shareholders,” Dr. Zeif concluded.
Financial Outlook:
Based on current market conditions, and assuming that the collective impact of global supply chain costs, rising interest rates, currency risk and inflation does not further worsen economic activity, the Company is updating its outlook for 2022 to include the impact of $17 million from its MakerBot divestiture as follows:
- Full year 2022 revenue of $648 million to $652 million, which includes the impact of approximately $13 million to reflect the anticipated impact of customer-related delays in the purchasing of systems and materials due to anticipated, ongoing economic uncertainty as well as ongoing pressure on foreign exchange rates. The updated outlook represents approximately 10% full year growth over 2021 after adjusting for the MakerBot divestiture.
- Full-year 2022 gross margins flat to slightly higher compared to full-year 2021, based on current logistics and materials costs.
- Full year-operating expenses $5 million to $10 million higher than 2021, primarily due to the divestiture of MakerBot and by improved efficiencies.
- Full year non-GAAP operating margins slightly above 2%.
- GAAP net loss of $48 million to $39 million, or ($0.72) to ($0.59) per diluted share.
- Non-GAAP net income of $6 million to $8 million, or $0.09 to $0.12 per diluted share.
- Adjusted EBITDA of $34 million to $37 million.
- Capital expenditures of $15 million to $20 million.
Non-GAAP earnings outlook excludes $37 million to $38 million of anticipated amortization of intangible assets, $33 million to $35 million of non-cash share-based compensation expense, $39 million gain from deconsolidation of MakerBot, and reorganization and other expenses of $14 million to $16 million. Non-GAAP outlook includes tax adjustments of $3 million to $5 million on the above non-GAAP items.
Appropriate reconciliations between GAAP and non-GAAP financial measures are provided in a table at the end of this press release and slide presentation, with itemized detail concerning the non-GAAP financial measures.
Stratasys Ltd. Third Quarter 2022 Webcast and Conference Call Details:
The Company plans to webcast its conference call to discuss its third quarter 2022 financial results on Thursday, November 10, 2022, at 8:30 a.m. (ET).
The investor conference call will be available via live webcast on the Stratasys website at investors.stratasys.com, or directly at the following web address:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=Aau6uFJK
To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least ten minutes prior to the call to register. The webcast will be available for six months at investors.stratasys.com, or by accessing the above-provided web address.
Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products and healthcare. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain. The world’s leading organizations turn to Stratasys to transform product design, bring agility to manufacturing and supply chains, and improve patient care.
To learn more about Stratasys, visit www.stratasys.com, the Stratasys blog, Twitter, LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including the Company’s websites, to share material, non-public information pursuant to the SEC’s Regulation FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings.
Stratasys is a registered trademark and the Stratasys signet is a trademark of Stratasys Ltd. and/or its subsidiaries or affiliates. All other trademarks are the property of their respective owners.
Cautionary Statement Regarding Forward-Looking Statements
The statements in this press release regarding Stratasys' strategy, and the statements regarding Stratasys’ projected future financial performance, including the financial guidance concerning its expected results for 2022 and beyond, are forward-looking statements reflecting management's current expectations and beliefs. These forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys' business, actual results could differ materially from those projected or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the degree of our success at introducing new or improved products and solutions that gain market share; the degree of growth of the 3D printing market generally; the impact of potential shifts in the prices or margins of the products that we sell or services that we provide, including due to a shift towards lower margin products or services; the impact of competition and new technologies; potential further charges against earnings that we could be required to take due to impairment of additional goodwill or other intangible assets; the extent of our success at successfully consummating and integrating into our existing business acquisitions or investments in new businesses, technologies, products or services; the degree of our success at locating and acquiring additional value-enhancing, inorganic technology that furthers our business plan to lead in the realm of polymers; the adverse impact that recent global interruptions, delays and increased costs related to freight carriers and other suppliers (including due to the Russian invasion of Ukraine) are having on our supply chain and distribution network, and, consequently, our ability to successfully sell both our existing and newly-launched 3D printing products; the strength and duration of, and degree of recovery from and resilience to, current adverse macro-economic conditions that are, in part, by-products of the COVID-19 pandemic, including inflation and rising interest rates, which are having, and may continue to have, significant consequences for our operations, financial position, cash flows, and those of our customers and suppliers; potential changes in our management and board of directors; global market, political and economic conditions, and in the countries in which we operate in particular; costs and potential liability relating to litigation and regulatory proceedings; risks related to infringement of our intellectual property rights by others or infringement of others' intellectual property rights by us; the extent of our success at maintaining our liquidity and financing our operations and capital needs; the impact of tax regulations on our results of operations and financial condition; and those additional factors referred to in Item 3.D “Key Information - Risk Factors”, Item 4, “Information on the Company”, Item 5, “Operating and Financial Review and Prospects,” and all other parts of our Annual Report on Form 20-F for the year ended December 31, 2021, which we filed with the U.S. Securities and Exchange Commission, or SEC, on February 24, 2022 (the “2021 Annual Report”). Readers are urged to carefully review and consider the various disclosures made throughout our 2021 Annual Report and the Reports of Foreign Private Issuer on Form 6-K that attach Stratasys’ unaudited, condensed consolidated financial statements and its review of its results of operations and financial condition, for the quarterly periods throughout 2022, which are furnished to the SEC throughout 2022, and our other reports filed with or furnished to the SEC, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects. Any guidance provided, and other forward-looking statements made, in this press release are provided or made (as applicable) as of the date hereof, and Stratasys undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Use of Non-GAAP Financial Measures
The non-GAAP data included herein, which exclude certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, legal provisions and currency-related fluctuations, and (ii) excluding non-cash items such as stock-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items. These factors eliminated in non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table below.
| Stratasys Ltd. | ||||||||
| Consolidated Balance Sheets | ||||||||
| (Unaudited) | ||||||||
| (in thousands, except share data) | ||||||||
| September 30, | December 31, | |||||||
2022 |
2021 |
|||||||
| ASSETS | ||||||||
| Current assets | ||||||||
| Cash and cash equivalents | $ |
150,672 |
|
$ |
243,179 |
|
||
| Short-term deposits |
|
198,056 |
|
|
259,000 |
|
||
| Accounts receivable, net of allowance for credit losses of $0.7 million and $0.5 million as of September 30, 2022 and December 31, 2021 |
|
140,258 |
|
|
129,382 |
|
||
| Inventories |
|
170,434 |
|
|
129,147 |
|
||
| Prepaid expenses |
|
8,146 |
|
|
6,871 |
|
||
| Other current assets |
|
26,838 |
|
|
33,123 |
|
||
| Total current assets |
|
694,404 |
|
|
800,702 |
|
||
| Non-current assets | ||||||||
| Property, plant and equipment, net |
|
194,214 |
|
|
203,295 |
|
||
| Goodwill |
|
64,844 |
|
|
65,144 |
|
||
| Other intangible assets, net |
|
129,682 |
|
|
152,244 |
|
||
| Operating lease right-of-use assets |
|
19,010 |
|
|
14,651 |
|
||
| Long-term investments |
|
143,928 |
|
|
28,667 |
|
||
| Other non-current assets |
|
21,309 |
|
|
12,519 |
|
||
| Total non-current assets |
|
572,987 |
|
|
476,520 |
|
||
| Total assets | $ |
1,267,391 |
|
$ |
1,277,222 |
|
||
| LIABILITIES AND EQUITY | ||||||||
| Current liabilities | ||||||||
| Accounts payable | $ |
67,957 |
|
$ |
51,976 |
|
||
| Accrued expenses and other current liabilities |
|
55,152 |
|
|
55,358 |
|
||
| Accrued compensation and related benefits |
|
34,862 |
|
|
44,684 |
|
||
| Deferred revenues - short term |
|
48,735 |
|
|
51,174 |
|
||
| Operating lease liabilities - short term |
|
6,977 |
|
|
7,276 |
|
||
| Total current liabilities |
|
213,683 |
|
|
210,468 |
|
||
| Non-current liabilities | ||||||||
| Deferred revenues - long term |
|
23,581 |
|
|
21,133 |
|
||
| Deferred income taxes - long term |
|
4,084 |
|
|
7,341 |
|
||
| Operating lease liabilities - long term |
|
11,738 |
|
|
7,693 |
|
||
| Contingent consideration - long term |
|
38,551 |
|
|
53,478 |
|
||
| Other non-current liabilities |
|
27,028 |
|
|
21,095 |
|
||
| Total non-current liabilities |
|
104,982 |
|
|
110,740 |
|
||
| Total liabilities |
|
318,665 |
|
|
321,208 |
|
||
| Equity | ||||||||
| Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands | ||||||||
| shares; 66,784 thousands shares and 65,677 thousands shares issued | ||||||||
| and outstanding at September 30, 2022 and December 31, 2021, respectively |
|
186 |
|
|
182 |
|
||
| Additional paid-in capital |
|
3,037,225 |
|
|
3,012,481 |
|
||
| Accumulated other comprehensive loss |
|
(14,223 |
) |
|
(8,771 |
) |
||
| Accumulated deficit |
|
(2,074,462 |
) |
|
(2,047,878 |
) |
||
|
948,726 |
|
|
956,014 |
|
|||
| Total liabilities and equity | $ |
1,267,391 |
|
$ |
1,277,222 |
|
||
| Stratasys Ltd. | |||||||||||||||
| Consolidated Statements of Operations | |||||||||||||||
| (in thousands, except per share data) | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2022 |
2021 |
2022 |
2021 |
||||||||||||
| (unaudited) | (unaudited) | (unaudited) | (unaudited) | ||||||||||||
| Net sales | |||||||||||||||
| Products | $ |
112,133 |
|
$ |
108,888 |
|
$ |
340,927 |
|
$ |
299,517 |
|
|||
| Services |
|
50,059 |
|
|
50,121 |
|
|
151,297 |
|
|
140,686 |
|
|||
|
162,192 |
|
|
159,009 |
|
|
492,224 |
|
|
440,203 |
|
||||
| Cost of sales | |||||||||||||||
| Products |
|
55,916 |
|
|
54,820 |
|
|
176,421 |
|
|
151,471 |
|
|||
| Services |
|
35,527 |
|
|
36,001 |
|
|
107,984 |
|
|
101,697 |
|
|||
|
91,443 |
|
|
90,821 |
|
|
284,405 |
|
|
253,168 |
|
||||
| Gross profit |
|
70,749 |
|
|
68,188 |
|
|
207,819 |
|
|
187,035 |
|
|||
| Operating expenses | |||||||||||||||
| Research and development, net |
|
23,145 |
|
|
22,645 |
|
|
71,489 |
|
|
65,683 |
|
|||
| Selling, general and administrative |
|
63,230 |
|
|
67,462 |
|
|
195,085 |
|
|
184,353 |
|
|||
|
86,375 |
|
|
90,107 |
|
|
266,574 |
|
|
250,036 |
|
||||
| Operating loss |
|
(15,626 |
) |
|
(21,919 |
) |
|
(58,755 |
) |
|
(63,001 |
) |
|||
| Gain from deconsolidation of subsidiary |
|
39,136 |
|
|
- |
|
|
39,136 |
|
|
- |
|
|||
| Financial income (expense), net |
|
452 |
|
|
(634 |
) |
|
(2,080 |
) |
|
(1,383 |
) |
|||
| Income (loss) before income taxes |
|
23,962 |
|
|
(22,553 |
) |
|
(21,699 |
) |
|
(64,384 |
) |
|||
| Income tax expense (benefit) |
|
3,298 |
|
|
699 |
|
|
2,796 |
|
|
6,009 |
|
|||
| Share in profit (losses) of associated companies |
|
(1,915 |
) |
|
3,778 |
|
|
(2,089 |
) |
|
1,229 |
|
|||
| Net income (loss) | $ |
18,749 |
|
$ |
(18,076 |
) |
$ |
(26,584 |
) |
$ |
(57,146 |
) |
|||
| Net income (loss) per share | |||||||||||||||
| Basic | $ |
0.28 |
|
$ |
(0.28 |
) |
$ |
(0.40 |
) |
$ |
(0.91 |
) |
|||
| Diluted | $ |
0.28 |
|
$ |
(0.28 |
) |
$ |
(0.40 |
) |
$ |
(0.91 |
) |
|||
| Weighted average ordinary shares outstanding | |||||||||||||||
| Basic |
|
66,772 |
|
|
65,018 |
|
|
66,356 |
|
|
62,888 |
|
|||
| Diluted |
|
67,038 |
|
|
65,018 |
|
|
66,356 |
|
|
62,888 |
|
|||
| Three Months Ended June 30, | |||||||||||||||||||||||
2022 |
Non-GAAP | 2022 |
2021 |
Non-GAAP | 2021 |
||||||||||||||||||
| GAAP | Adjustments | Non-GAAP | GAAP | Adjustments | Non-GAAP | ||||||||||||||||||
| U.S. dollars and shares in thousands (except per share amounts) | |||||||||||||||||||||||
| Gross profit (1) | $ |
70,749 |
|
$ |
7,990 |
|
$ |
78,739 |
$ |
68,188 |
|
$ |
8,507 |
|
$ |
76,695 |
|||||||
| Operating income (loss) (1,2) |
|
(15,626 |
) |
|
20,149 |
|
|
4,523 |
|
(21,919 |
) |
|
23,739 |
|
|
1,820 |
|||||||
| Net income (loss) (1,2,3) |
|
18,749 |
|
|
(15,423 |
) |
|
3,326 |
|
(18,076 |
) |
|
18,592 |
|
|
516 |
|||||||
| Net income (loss) per diluted share (4) | $ |
0.28 |
|
$ |
(0.23 |
) |
$ |
0.05 |
$ |
(0.28 |
) |
$ |
0.28 |
|
$ |
0.01 |
|||||||
(1) |
Acquired intangible assets amortization expense |
|
6,941 |
|
|
5,495 |
|
||||||||||||||||
| Non-cash stock-based compensation expense |
|
1,061 |
|
|
804 |
|
|||||||||||||||||
| Restructuring and other related costs |
|
(12 |
) |
|
67 |
|
|||||||||||||||||
| Impairment charges |
|
- |
|
|
2,141 |
|
|||||||||||||||||
|
7,990 |
|
|
8,507 |
|
||||||||||||||||||
(2) |
Acquired intangible assets amortization expense |
|
2,138 |
|
|
2,205 |
|
||||||||||||||||
| Non-cash stock-based compensation expense |
|
6,330 |
|
|
7,154 |
|
|||||||||||||||||
| Impairment of long-lived assets |
|
- |
|
|
1,242 |
|
|||||||||||||||||
| Restructuring and other related costs |
|
1,309 |
|
|
210 |
|
|||||||||||||||||
| Revaluation of investments |
|
901 |
|
|
2,025 |
|
|||||||||||||||||
| Contingent consideration |
|
394 |
|
|
197 |
|
|||||||||||||||||
| Other expenses |
|
1,087 |
|
|
2,199 |
|
|||||||||||||||||
|
12,158 |
|
|
15,232 |
|
||||||||||||||||||
|
20,149 |
|
|
23,739 |
|
||||||||||||||||||
(3) |
Gain from deconsolidation of subsidiary |
|
(39,136 |
) |
|
- |
|
||||||||||||||||
| Corresponding tax effect and other expenses |
|
3,564 |
|
|
(5,147 |
) |
|||||||||||||||||
$ |
(15,423 |
) |
$ |
18,592 |
|
||||||||||||||||||
(4) |
Weighted average number of ordinary
shares outstanding - Diluted |
|
67,038 |
|
|
67,038 |
|
65,018 |
|
|
65,950 |
||||||||||||
| Six Months Ended June 30, | ||||||||||||||||||||||||
2022 |
Non-GAAP | 2022 |
2021 |
Non-GAAP | 2021 |
|||||||||||||||||||
| GAAP | Adjustments | Non-GAAP | GAAP | Adjustments | Non-GAAP | |||||||||||||||||||
| U.S. dollars and shares in thousands (except per share amounts) | ||||||||||||||||||||||||
| Gross profit (1) | $ |
207,819 |
|
$ |
27,593 |
|
$ |
235,412 |
$ |
187,035 |
|
$ |
22,192 |
|
$ |
209,227 |
|
|||||||
| Operating income (loss) (1,2) |
|
(58,755 |
) |
|
67,235 |
|
|
8,480 |
|
(63,001 |
) |
|
59,657 |
|
|
(3,344 |
) |
|||||||
| Net income (loss) (1,2,3) |
|
(26,584 |
) |
|
32,295 |
|
|
5,711 |
|
(57,146 |
) |
|
52,284 |
|
|
(4,862 |
) |
|||||||
| Net income (loss) per diluted share (4) | $ |
(0.40 |
) |
$ |
0.49 |
|
$ |
0.09 |
$ |
(0.91 |
) |
$ |
0.83 |
|
$ |
(0.08 |
) |
|||||||
(1) |
Acquired intangible assets amortization expense |
|
20,861 |
|
|
16,368 |
|
|||||||||||||||||
| Non-cash stock-based compensation expense |
|
3,041 |
|
|
2,226 |
|
||||||||||||||||||
| Restructuring and other related costs |
|
(174 |
) |
|
1,457 |
|
||||||||||||||||||
| Impairment charges |
|
3,865 |
|
|
2,141 |
|
||||||||||||||||||
|
27,593 |
|
|
22,192 |
|
|||||||||||||||||||
(2) |
Acquired intangible assets amortization expense |
|
6,581 |
|
|
6,598 |
|
|||||||||||||||||
| Non-cash stock-based compensation expense |
|
21,714 |
|
|
20,914 |
|
||||||||||||||||||
| Impairment of long-lived assets |
|
- |
|
|
2,664 |
|
||||||||||||||||||
| Restructuring and other related costs |
|
1,864 |
|
|
2,370 |
|
||||||||||||||||||
| Revaluation of investments |
|
3,217 |
|
|
556 |
|
||||||||||||||||||
| Contingent consideration |
|
1,197 |
|
|
590 |
|
||||||||||||||||||
| Other expenses |
|
5,069 |
|
|
3,773 |
|
||||||||||||||||||
|
39,642 |
|
|
37,465 |
|
|||||||||||||||||||
|
67,235 |
|
|
59,657 |
|
|||||||||||||||||||
(3) |
Gain from deconsolidation of subsidiary |
|
(39,136 |
) |
|
- |
|
|||||||||||||||||
| Corresponding tax effect and other expenses |
|
4,196 |
|
|
(7,373 |
) |
||||||||||||||||||
$ |
32,295 |
|
$ |
52,284 |
|
|||||||||||||||||||
(4) |
Weighted average number of ordinary
shares outstanding - Diluted |
|
66,356 |
|
|
67,007 |
|
62,888 |
|
|
62,888 |
|
||||||||||||
| Stratasys Ltd. | ||
| Reconciliation of GAAP to Non-GAAP Forward Looking Guidance | ||
| Fiscal Year 2022 | ||
| (in millions, except per share data) | ||
| GAAP net loss | ($48) to ($39) | |
| Adjustments | ||
| Stock-based compensation expense | $33 to $35 | |
| Intangible assets amortization expense | $37 to $38 | |
| Reorganization and other | $14 to $16 | |
| Tax expense (benefit) related to Non-GAAP adjustments | $3 to $5 | |
| Non-GAAP net income | $6 to $8 | |
| GAAP loss per share | ($0.72) to ($0.59) | |
| Non-GAAP diluted earnings per share | $0.09 to $0.12 | |
View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005307/en/
Contact:
Yonah Lloyd
CCO, VP Investor Relations
Yonah.Lloyd@stratasys.com